BenevolentAI
在场
BenevolentAI 是一家在股票代码 BAI (GB) 下上市的公司。
高管
查看带有其 42 名主要高管的组织结构图
BenevolentAI 搜索最多的简介
- Joerg Moeller, Chief Executive Officer and Executive Board Member
- Nigel Shadbolt, Director
- John Orloff, Director
高管在BenevolentAI变化
- Susan Liautaud, Director, 已经离开公司 (新闻发布的2024五月3号).
- François Nader, Independent Non-Executive Chairman of the Board, 将于 20245月2 退休 (新闻发布的2024四月16号).
- Kenneth Mulvany已作为Deputy Chairman of the Board加入公司 (新闻发布的2024四月16号).
创建提醒
跟踪 BenevolentAI 的高管变动
生物技术
BenevolentAI 拥有 2,284 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Karius 刚刚宣布为 100 筹款数百万美元。 (公布2024五月3号).
- Transcarent 刚刚宣布为 126 筹款数百万美元。 (公布2024五月2号).
- WindRose Health Investors has announced the acquisition of SubjectWell (公布2024五月2号).
生物技术 行业的其他推荐联系人
消息
BenevolentAI 的最新新闻稿
- BenevolentAI provides an update on its business priorities
- BenevolentAI provides an update on its business priorities
- BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial
- Proposed changes to BenevolentAI's Board composition
- BenevolentAI CEO Dr Joerg Moeller discusses AI's impact on drug discovery
- Publication of the Revised Agenda for the 2024 AGM
- Proposed changes to BenevolentAI's Board composition
- BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial
- Publication of the Revised Agenda for the 2024 AGM
- BenevolentAI appoints new Chief Technology Officer
- View more press releases Close
通过电子邮件
